About this trial

Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.

Eligibility criteria

Qualifiers

Deceased donor kidney transplantation at KCMH

informed consent is accepted

Disqualifiers

Known allergy to furosemide

Surgical complication of allograft

Urgently needed for dialysis (refractory hypervolemia, uremic symptoms, and hyperkalemia)

Trial design

Treatments tested in this trial

  • Furosemide Injection

Treatment groups

180 Participants
are divided into 1 treatment group

Locations

1
King Chulalongkorn Memorial Hospital10330, Bangkok Thailand

Sponsors and collaborators

King Chulalongkorn Memorial Hospital

Lead sponsor